Imagine trying to find a few specific needles in a giant haystack of biological fluid; usually, this takes forever and is very messy. This technology acts like a high-tech magnet and scanner combined, pulling out the exact 'needles' (vesicles) you need while counting them instantly. It replaces slow, manual spinning machines with a fast, automated light-based sensor.
Current EV isolation and quantification methods are slow, costly, and imprecise, often introducing bias that hinders clinical diagnostics and bioprocessing. This lack of standardization prevents the use of EVs in reliable cancer and cardiovascular disease screening.
An automated fiber-optic platform with a sensor dip probe for label-free EV isolation and quantification, and a high-purity isolation kit.
If you are a diagnostic lab dealing with slow and imprecise EV quantification in crude samples — this project developed a fiber-optic sensor dip probe that allows for accurate quantification and purity >95%. This can reduce healthcare costs by >5% through earlier diagnosis and better patient stratification.
If you are a biotech company dealing with labor-intensive ultracentrifugation that biases your samples — this project developed an automated platform that is 24 times faster and provides high purity (>95%). This enables a more reliable transition from R&D to clinical insights.
If you are a manufacturer dealing with the lack of standardized tools for EV isolation in bioreactors — this project developed a scalable (4x) automated platform. It allows for the release of quantified EVs for further content analysis with hands-on time < 20 min.
Based on available project data, the improvement in EV diagnostics for cancer and cardiovascular diseases has the potential to reduce associated healthcare costs by >5%.
Yes, the project objective specifies that the automated platform is scalable 4x.
Based on available project data, the technology is developed by FOX BIOSYSTEMS NV, but specific licensing terms are not provided in the summary.
The new method is 24 times faster than current solutions, with hands-on time reduced to < 20 min.
The system uses a sensor dip probe that allows for the direct quantification of EVs from crude samples without the bias introduced by traditional filters.
The project is led by a single Belgian SME, FOX BIOSYSTEMS NV, with a 100% industry ratio. This lean structure suggests a highly focused commercial drive, as the coordinator is the sole developer and beneficiary of the EUR 2,499,999 EU contribution, minimizing coordination overhead and accelerating the path to market.
Contact FOX BIOSYSTEMS NV in Belgium for commercial inquiries regarding the FOx affinity isolation platform.
Contact us to explore licensing or partnership opportunities with FOX BIOSYSTEMS NV.
